Viral Vaccines (economics) < Viral Vaccines (genetics) < Viral Vaccines (immunology)

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 57.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000659 (2004)	Zhi-Yong Yang [États-Unis] ; Wing-Pui Kong ; Yue Huang ; Anjeanette Roberts ; Brian R. Murphy ; Kanta Subbarao ; Gary J. Nabel	A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.
000900 (2004)	Ursula J. Buchholz [États-Unis] ; Alexander Bukreyev ; Lijuan Yang ; Elaine W. Lamirande ; Brian R. Murphy ; Kanta Subbarao ; Peter L. Collins	Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.
000C62 (2005)	Alexander N. Zakhartchouk [Canada] ; Sathiyanarayanan Viswanathan [Canada] ; James B. Mahony [Canada] ; Jack Gauldie [Canada] ; Lorne A. Babiuk [Canada]	Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice.
000D83 (2005)	Zhiwei Chen ; Linqi Zhang ; Chuan Qin ; Lei Ba ; Christopher E. Yi ; Fengwen Zhang ; Qiang Wei ; Tian He ; Wenjie Yu ; Jian Yu ; Hong Gao ; Xinming Tu ; Agegnehu Gettie ; Michael Farzan ; Kwok-Yung Yuen ; David D. Ho	Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding Region
000E11 (2005)	Yuxian He [États-Unis] ; Qingyu Zhu [République populaire de Chine] ; Shuwen Liu [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Baoan Yang [République populaire de Chine] ; Jiaming Li [République populaire de Chine] ; Shibo Jiang [États-Unis]	Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines
000E20 (2005)	Masaji Okada [Japon] ; Yuji Takemoto [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Shigeto Yoshida [Japon] ; Yukari Fukunaga [Japon] ; Takao Tanaka [Japon] ; Yoko Kita [Japon] ; Sachiko Kuwayama [Japon] ; Yumiko Muraki [Japon] ; Noriko Kanamaru [Japon] ; Hiroko Takai [Japon] ; Chika Okada [Japon] ; Yayoi Sakaguchi [Japon] ; Izumi Furukawa [Japon] ; Kyoko Yamada [Japon] ; Makoto Matsumoto [Japon] ; Tetsuo Kase [Japon] ; Daphne E. Demello [États-Unis] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]	The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
000E21 (2005)	Markus Czub [Canada] ; Hana Weingartl [Canada] ; Stefanie Czub [Canada] ; Runtao He [Canada] ; Jingxin Cao [Canada]	Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
000E47 (2005)	Himani Bisht [États-Unis] ; Anjeanette Roberts ; Leatrice Vogel ; Kanta Subbarao ; Bernard Moss	Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein.
000E96 (2005)	Milosz Faber ; Elaine W. Lamirande [États-Unis] ; Anjeanette Roberts [États-Unis] ; Amy B. Rice ; Hilary Koprowski ; Bernhard Dietzschold ; Matthias J. Schnell [États-Unis]	A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies
000F35 (2005)	Yi-Tang Li ; Gui-Fang Cheng	[The advances in basal research of SARS CoV].
001032 (2005)	Derrick Louz [Pays-Bas] ; Hans E. Bergmans ; Birgit P. Loos ; Rob C. Hoeben	Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines.
001062 (2005)	Ran-Yi Liu [République populaire de Chine] ; Li-Zhi Wu ; Bi-Jun Huang ; Jia-Ling Huang ; Yan-Ling Zhang ; Miao-La Ke ; Jun-Mei Wang ; Wei-Ping Tan ; Ru-Hua Zhang ; Han-Kui Chen ; Yi-Xin Zeng ; Wenlin Huang	Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.
001145 (2005)	Christopher E. Yi [États-Unis] ; Lei Ba [États-Unis] ; Linqi Zhang [États-Unis] ; David D. Ho [États-Unis] ; Zhiwei Chen [États-Unis]	Single Amino Acid Substitutions in the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Determine Viral Entry and Immunogenicity of a Major Neutralizing Domain
001182 (2005)	Yan Zhi [États-Unis] ; James M. Wilson ; Hao Shen	SARS vaccine: progress and challenge.
001200 (2004)	Minsheng Zhu [République populaire de Chine]	SARS Immunity and Vaccination.
001252 (2005)	Jing Chen [République populaire de Chine] ; Lin Miao ; Jia-Ming Li ; Yan-Ying Li ; Qing-Yu Zhu ; Chang-Lin Zhou ; Hong-Qing Fang ; Hui-Peng Chen	Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.
001324 (2006)	Vandana Gupta [Singapour] ; Tani M. Tabiin ; Kai Sun ; Ananth Chandrasekaran ; Azlinda Anwar ; Kun Yang ; Priya Chikhlikar ; Jerome Salmon ; Vladimir Brusic ; Ernesto T A. Marques ; Srinivasan N. Kellathur ; Thomas J. August	SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens.
001457 (2006)	Yuxian He ; Jingjing Li ; Shibo Jiang	A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity
001A03 (2007)	Lei Ba ; Christopher E. Yi ; Linqi Zhang ; David D. Ho ; Zhiwei Chen	Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus
001A06 (2007)	Fengling Luo [République populaire de Chine] ; Yong Feng ; Min Liu ; Pingfei Li ; Qin Pan ; Victor Tunje Jeza ; Bing Xia ; Jianguo Wu ; Xiao-Lian Zhang	Type IVB pilus operon promoter controlling expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid gene in Salmonella enterica Serovar Typhi elicits full immune response by intranasal vaccination.
001A29 (2007)	Alexander N. Zakhartchouk [Canada] ; Sathiyanarayanan Viswanathan ; Igor Moshynskyy ; Martin Petric ; Lorne A. Babiuk	Optimization of a DNA vaccine against SARS.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Viral Vaccines (genetics)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Viral Vaccines (genetics)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Viral Vaccines (genetics)
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021